117 related articles for article (PubMed ID: 38554323)
21. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Kumagai K; Yamada T; Terashima M; Yabusaki H; Nishikawa K; Tanabe K; Yunome G; Kawachi Y; Yamada T; Fukagawa T; Kinoshita T; Watanabe M; Ishiyama K; Inoue K; Boku N
Gastric Cancer; 2023 Mar; 26(2):307-316. PubMed ID: 36695982
[TBL] [Abstract][Full Text] [Related]
22. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
[TBL] [Abstract][Full Text] [Related]
23. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
25. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of surgical resection after induction chemotherapy for patients with T4b squamous cell head and neck cancer.
Rivera F; Eugenia Vega-Villegas M; López C; Francisca López-Brea M; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Hinojo C; Márquez R; Angel Alonso-Bermejo M; Salcedo M; Blanco Y; Vega N; López-Tarruella S; Sanz-Ortiz J
Acta Oncol; 2008; 47(8):1584-9. PubMed ID: 18607841
[TBL] [Abstract][Full Text] [Related]
27. Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients.
Wang N; Jiang J; Xi W; Wu J; Zhou C; Shi M; Wang C; Zhu Z; Liu J; Zhang J
Int J Med Sci; 2020; 17(15):2276-2284. PubMed ID: 32922192
[No Abstract] [Full Text] [Related]
28. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastases.
Han DS; Suh YS; Kong SH; Lee HJ; Im SA; Bang YJ; Kim WH; Yang HK
J Surg Oncol; 2013 Apr; 107(5):511-6. PubMed ID: 23090791
[TBL] [Abstract][Full Text] [Related]
30. Cholinesterase is Associated With Prognosis and Response to Chemotherapy in Advanced Gastric Cancer.
Bi Y; Zhang J; Zeng D; Chen L; Ye W; Yang Q; Ling Y
Pathol Oncol Res; 2021; 27():580800. PubMed ID: 34257526
[No Abstract] [Full Text] [Related]
31. Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?
Su P; Zhang Y; Yu T; Jiang L; Kang W; Liu Y; Yu J
World J Surg Oncol; 2022 Dec; 20(1):408. PubMed ID: 36572874
[TBL] [Abstract][Full Text] [Related]
32. Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.
Pacelli F; Cusumano G; Rosa F; Marrelli D; Dicosmo M; Cipollari C; Marchet A; Scaringi S; Rausei S; di Leo A; Roviello F; de Manzoni G; Nitti D; Tonelli F; Doglietto GB;
JAMA Surg; 2013 Apr; 148(4):353-60. PubMed ID: 23715879
[TBL] [Abstract][Full Text] [Related]
33. Effects of Neoadjuvant Chemotherapy Toxicity and Postoperative Complications on Short-term and Long-term Outcomes After Curative Resection of Gastric Cancer.
Wu C; Wang N; Zhou H; Wang T; Mao Q; Zhang X; Zhao D
J Gastrointest Surg; 2020 Jun; 24(6):1278-1289. PubMed ID: 31140064
[TBL] [Abstract][Full Text] [Related]
34. Safety and Efficacy of Simultaneous Resection of Gastric Carcinoma and Synchronous Liver Metastasis-A Western Center Experience.
Minciuna CE; Tudor S; Micu A; Diaconescu A; Alexandrescu ST; Vasilescu C
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557004
[No Abstract] [Full Text] [Related]
35. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery.
Shimoda Y; Fujikawa H; Komori K; Watanabe H; Kano K; Yamada T; Shiozawa M; Morinaga S; Katsumata K; Tsuchida A; Ogata T; Oshima T
Anticancer Res; 2021 Feb; 41(2):1005-1012. PubMed ID: 33517308
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Role of Conversion Surgery for Unresectable Gastric Cancer.
Fukuchi M; Ishiguro T; Ogata K; Suzuki O; Kumagai Y; Ishibashi K; Ishida H; Kuwano H; Mochiki E
Ann Surg Oncol; 2015 Oct; 22(11):3618-24. PubMed ID: 25663597
[TBL] [Abstract][Full Text] [Related]
38. ypTNM staging is a potentially useful prognostic stratification tool in patients with advanced gastric cancer after preoperative chemotherapy.
Otsuka R; Hayano K; Hayashi H; Uesato M; Murakami K; Toyozumi T; Matsumoto Y; Kurata Y; Nakano A; Matsubara H
Langenbecks Arch Surg; 2023 Mar; 408(1):133. PubMed ID: 37000278
[TBL] [Abstract][Full Text] [Related]
39. Conversion surgery for stage IV gastric cancer: a multicenter retrospective study.
Kano Y; Ichikawa H; Hanyu T; Muneoka Y; Ishikawa T; Aizawa M; Matsuki A; Yabusaki H; Bamba T; Nakagawa S; Kobayashi K; Kuwabara S; Makino S; Kawachi Y; Naito T; Tani T; Hirukawa H; Tada T; Shimada Y; Sakata J; Wakai T
BMC Surg; 2022 Dec; 22(1):428. PubMed ID: 36517780
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study.
Ebata Y; Nakanishi R; Tanaka Y; Kawazoe T; Tajiri H; Zaitsu Y; Nakashima Y; Ota M; Oki E; Yoshizumi T
Anticancer Res; 2024 Mar; 44(3):1281-1287. PubMed ID: 38423645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
